Navigation Links
Scientists Discover Why Teeth Form in a Single Row
Date:2/26/2009

ecial quality of epithelial cells there made them "tooth competent." Classical experiments, however, found that the developing tooth mesenchyme was capable of inducing tooth formation from epithelial tissues that normally would not participate in tooth development. Researchers confirmed that it was indeed the mesenchyme that carried tooth initiation signals later in development, but how those signals were restricted to the area beneath the tooth row was unknown.

Past studies in other labs had shown bone morphogenic protein 4 (BMP4) to be an important factor for the initiation of teeth, and that a protein called Msx1 amplifies the BMP4 tooth-generating signal. Jiang and colleagues suggested for the first time that some unknown factor was restricting the growth of teeth into one row by opposing the Bmp4 signal.

The current study provides the first solid proof that the precise space where mammals can develop teeth (the "tooth morphogenetic field") is shaped and restricted by the effect of Osr2 on the expression of the Bmp4 gene within the mesenchymal cell layer. Jiang's team has shown not only that removing the Osr2 gene results in extra teeth outside of the normal row, but also that Osr2 is expressed in increasing concentration in the jaw mesenchyme as you move from the cheek toward the tongue in the mouse embryo, the exact opposite of the BMP4 concentration gradient. Osr2 restricts Bmp4 expression to the tooth mesenchyme under the dental lamina, and in Osr2's absence, Bmp4 gene expression expands into the jaw mesenchyme outside of the tooth row.

A second major finding of the study backs up another emerging theory which holds that careful regulation of competing pro- and anti-tooth initiation signals controls how mammalian teeth come one by one in sequence. As each tooth develops, something must prevent it from forming too close to the next or mammals would have no gaps between their teeth. When this mechanism occas
'/>"/>

SOURCE University of Rochester Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Scientists Unmask Genetic Markers Associated With Psoriasis
2. 42 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases
3. Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report
4. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
5. Scientists Reveal Roadmap to Brain Health That Can Be Passed Down to Future Generations: Exercise, Omega-3, Folic Acid, Vitamin B6, and Vitamin B12
6. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
7. Brain Stem Cells Can Be Awakened, Say Schepens Scientists
8. Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
9. ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India
10. Neuroscientists Offer Hope for Breast Cancer Patients Suffering From Chemobrain
11. Researchers Discover Metabolite Linked to Aggressive Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...wire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulleti...lanta-based, biopharmaceutical company developing ... Immunodeficiency Virus) and other infectious agen...al results and provided an operational update. ,...utive Officer commented, "We are pleased with our ...
(Date:11/6/2009)...PRNewswire/ -- , - Trial Will Compare NXL...tment of Multi-Resistant Staphylococcus Aureus (MR...armaceutical company focused on the discovery and,...ome the significant global,problem of microbial re...ral,antibacterial NXL103 (flopristin/linopristin),...
(Date:11/5/2009)... Helix BioPharma Corp. (...at its Phase II trial of Topical Interferon Alpha-...s completed patient enrollment, with the required ... The double-blind and placebo-controlled Phase II ...nd Sweden. Patients participating in the trial se...
Breaking Medicine Technology:GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Team24 News Article New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 52479 1Team24 News Article New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 52479 2Team24 News Article New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 52479 3Burner Balm Gets International Attention 52477 1Burner Balm Gets International Attention 52477 2Takeda Provides Update on the Investigational Fixed Dose Combination of alogliptin and ACTOS 28R 29 28pioglitazone HCl 29 4769 1Takeda Provides Update on the Investigational Fixed Dose Combination of alogliptin and ACTOS 28R 29 28pioglitazone HCl 29 4769 2Takeda Provides Update on the Investigational Fixed Dose Combination of alogliptin and ACTOS 28R 29 28pioglitazone HCl 29 4769 3
...AIRFAX, Va., Aug. 2 The American Society,for Ther...rochure Radiation,Therapy for Lymphoma, a short tr...,s and non-Hodgkin,s lymphoma. The brochure outlin...lains radiation therapy,s role in,treatment and wh...diation,therapy. "A cancer diagnosis can be very ...
...HILADELPHIA, Aug. 3 GlaxoSmithKline (NYSE:,GSK), ...today announced,that HHS has placed another order ...stockpile of pre-pandemic vaccines. The company al... pre-pandemic vaccine trials in the,company,s glob... company has received a second task order for 22.5...
Other Medicine Technology:GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSK's Candidate Pre-pandemic Flu Vaccine to Start. 2GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSK's Candidate Pre-pandemic Flu Vaccine to Start. 3GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSK's Candidate Pre-pandemic Flu Vaccine to Start. 4
(Date:11/8/2009)...es House Passage of Health Care Reform Bill ,,...improve coverage for all Americans ,, BALTIMOR...night the United States House of Representatives p... would strengthen Medicare for seniors and end dis...lions of Americans out of affordable health covera...
(Date:11/7/2009)...v. 7, The American Medi...min Rush Award for Citizenship and Community Servi...m Chicago, IL. The award recognizes physicians who...l of duty to make an outstanding public service co...eived the award today during the opening session o...
(Date:11/7/2009)...v. 7 Members of the AMA...mergency resolution rescinding the AMA,s support o...at they are responsible to their PATIENTS, not the...ctor of Policy for the Association of American Phy...alition of other medical groups. ,, "If the AM...
(Date:11/7/2009)... Nov. 7 Speaker Nancy P...lity this afternoon following a Democratic Whip me...om. Below are the Speaker,s opening remarks: ,...great occasion for us to receive the President of ...ng history with our vote and making progress for t...
(Date:11/7/2009)... to stem a growing problem across the U.S. , ...alf of students at four-year colleges do it regula...king -- downing five or more alcoholic drinks at a...lcohol as a drug," said Jenny Hwang, associate dea...r at Stony Brook University on Long Island, N.Y. I...
Breaking Medicine News(10 mins):Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3
...ng their example from movies, and starting to expe...h// study has measured the influence of alcohol u...lms and 5,000 students, found that movies play a s...udies on Alcohol and the authors cite previous res...
...Lee Kennedy and other medical experts from Townsvi...bese// population in North Queensland. The aut...ferent population but none has been conducted on t... be managed in the poulaion is also very helpful. ...
...rovided to people who wish to give up smoking in O...age of 18 years// will benefit from this scheme. T...ment for Ontario Patients (STOP) Study, which will...on and Mental Health’s (CAMH) Dr. Peter Selby. ...
...spital admissions which are unnecessary is at risk...heir own budgets// . The proposals of the Governme... will enable better access to sexual health clinic...is responsibility, and without the active cooperat...
... usefulness of the antibiotic metronidazole. This ...n before their full term// (22-36 weeks). Western ...s. This dug was prescribed usually to pregnant...otic was usually administered to prevent the risk ...
... facilities will be available for rural people, wh... and diagnosis.// NHS Lothian will be organizing m...nics. Endoscopic procedures are mostly useful in d...s biopsy specimens can also be collected using end...
Other Medicine News:
Weiss Retinal Pick 90 Degree Short
Kellan Nucleus Rotator
Lambert 90 Degree Pick
Azar Lens Manipulation hook
Medicine Products: